Travis Dunckley

Assistant Research Professor

Assistant Research Professor, Biodesign: ASU-Banner Neurodegenerative Disease Research Center (NDRC)

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Travis Dunckley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

3 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3808 Citations
25 h-Index
36 Article
6 Review article
3 Chapter
2 Comment/debate

Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
Velazquez, R., Meechoovet, B., Ow, A., Foley, C., Shaw, A., Smith, B., Oddo, S., Hulme, C. & Dunckley, T., Dec 1 2019, In: Molecular Neurobiology. 56, 12, p. 8364-8375 12 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood
Harvard Biomarkers Study investigators are listed in the Acknowledgement section, Apr 3 2019, In: Epigenetics. 14, 4, p. 365-382 18 p.
Research output: Contribution to journal › Article › peer-review
13 Scopus citations
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
The ITALSGEN Consortium & The International ALS Genomics Consortium, Apr 1 2019, In: Annals of Neurology. 85, 4, p. 470-481 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
33 Scopus citations
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
ITALSGEN Consortium, Genomic Translation for ALS Care (GTAC) Consortium, ALS Sequencing Consortium, NYGC ALS Consortium, Answer ALS Foundation, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium & Project MinE ALS Sequencing Consortium, Mar 21 2018, In: Neuron. 97, 6, p. 1268-1283.e6
Research output: Contribution to journal › Article › peer-review
159 Scopus citations
Dyrk1 inhibition improves Alzheimer's disease-like pathology
Branca, C., Shaw, D. M., Belfiore, R., Gokhale, V., Shaw, A. Y., Foley, C., Smith, B., Hulme, C., Dunckley, T., Meechoovet, B., Caccamo, A. & Oddo, S., Oct 2017, In: Aging Cell. 16, 5, p. 1146-1154 9 p.
Research output: Contribution to journal › Article › peer-review
37 Scopus citations

1 Active
5 Finished

Comprehensive Methylation Profiling of the PPMI Cohort
Dunckley, T.
Michael J. Fox Foundation
10/1/18 → 4/14/23
Project: Research project
DYRK1A inhibition as a novel treatment approach for Alzheimer's disease - Resubmission
Dunckley, T.
HHS: National Institutes of Health (NIH)
4/1/20 → 2/28/21
Project: Research project
Optimization of Selective DYRK1A Inhibitors as a Treatment for AD
Dunckley, T.
Alzheimer's Drug Discovery Foundation
6/1/18 → 5/31/19
Project: Research project
Development of selective DYRK1A inhibitors as a treatment for Alzheimers disease
Dunckley, T.
Harrington Discovery Institute
1/4/17 → 12/31/19
Project: Research project
Testing of selective DYRK1A inhibitors as a novel treatment of AD
Dunckley, T.
Alzheimer's Drug Discovery Foundation
4/1/16 → 2/28/18
Project: Research project